Clínica Baviera SA

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: ES0119037010
EUR
56.40
13.4 (31.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.34 k

Shareholding (Mar 2010)

FII

0.00%

Held by 0 FIIs

DII

100.00%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 42.94%, it has a Very Expensive valuation with a 8.62 Price to Book Value

  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 47.64%, its profits have risen by 9.4% ; the PEG ratio of the company is 2.1
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

EUR 913 Million ()

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.80%

stock-summary
Debt Equity

-0.59

stock-summary
Return on Equity

39.04%

stock-summary
Price to Book

8.30

Revenue and Profits:
Net Sales:
82 Million
(Quarterly Results - Dec 2025)
Net Profit:
15 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
61.14%
0%
61.14%
6 Months
70.91%
0%
70.91%
1 Year
105.09%
0%
105.09%
2 Years
216.85%
0%
216.85%
3 Years
157.53%
0%
157.53%
4 Years
276.0%
0%
276.0%
5 Years
493.68%
0%
493.68%

Clínica Baviera SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
24.40%
EBIT Growth (5y)
38.07%
EBIT to Interest (avg)
40.48
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
2.41
Tax Ratio
27.22%
Dividend Payout Ratio
48.42%
Pledged Shares
0
Institutional Holding
0.12%
ROCE (avg)
93.51%
ROE (avg)
40.00%

Valuation key factors

Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
8.62
EV to EBIT
13.42
EV to EBITDA
9.62
EV to Capital Employed
13.05
EV to Sales
2.71
PEG Ratio
2.13
Dividend Yield
3.08%
ROCE (Latest)
97.26%
ROE (Latest)
42.94%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2010stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 10.85% vs 20.23% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 11.45% vs 33.67% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.70",
          "val2": "73.70",
          "chgp": "10.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.10",
          "val2": "23.40",
          "chgp": "7.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.60",
          "val2": "13.10",
          "chgp": "11.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "229.50%",
          "val2": "238.50%",
          "chgp": "-0.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 14.93% vs 16.76% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 4.38% vs 11.99% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "301.80",
          "val2": "262.60",
          "chgp": "14.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "106.10",
          "val2": "92.80",
          "chgp": "14.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "1.20",
          "chgp": "91.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "42.90",
          "val2": "41.10",
          "chgp": "4.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "272.50%",
          "val2": "273.90%",
          "chgp": "-0.14%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
81.70
73.70
10.85%
Operating Profit (PBDIT) excl Other Income
25.10
23.40
7.26%
Interest
0.00
0.40
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.60
13.10
11.45%
Operating Profit Margin (Excl OI)
229.50%
238.50%
-0.90%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 10.85% vs 20.23% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 11.45% vs 33.67% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
301.80
262.60
14.93%
Operating Profit (PBDIT) excl Other Income
106.10
92.80
14.33%
Interest
2.30
1.20
91.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
42.90
41.10
4.38%
Operating Profit Margin (Excl OI)
272.50%
273.90%
-0.14%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 14.93% vs 16.76% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 4.38% vs 11.99% in Dec 2024

stock-summaryCompany CV
About Clínica Baviera SA stock-summary
stock-summary
Clínica Baviera SA
Hospital
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available